|
|
|
Volumn 29, Issue SUPPL. 65, 2002, Pages 22-26
|
|
Tides of inflammation: Impact of biologics
|
|
Author keywords
Anakinra; Etanercept; Infliximab cytokines; Rheumatoid arthritis
|
|
Indexed keywords
ETANERCEPT;
IMMUNOMODULATING AGENT;
INFLIXIMAB;
INTERLEUKIN 1;
METHOTREXATE;
RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;
TUMOR NECROSIS FACTOR ALPHA;
ANTIRHEUMATIC AGENT;
BIOLOGICAL PRODUCT;
IL1RN PROTEIN, HUMAN;
IMMUNOGLOBULIN G;
INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;
MONOCLONAL ANTIBODY;
SIALOGLYCOPROTEIN;
TNFR FC FUSION PROTEIN;
TNFR-FC FUSION PROTEIN;
TUMOR NECROSIS FACTOR RECEPTOR;
ANTIINFLAMMATORY ACTIVITY;
ARTICLE;
DRUG EFFICACY;
DRUG RESEARCH;
HUMAN;
IMMUNOMODULATION;
IMMUNOTHERAPY;
PRIORITY JOURNAL;
RHEUMATOID ARTHRITIS;
CLINICAL TRIAL;
COMPARATIVE STUDY;
DRUG EFFECT;
FEMALE;
FOLLOW UP;
HOSPITALIZATION;
JOINT CHARACTERISTICS AND FUNCTIONS;
MALE;
PAIN ASSESSMENT;
REVIEW;
TREATMENT OUTCOME;
ANTIBODIES, MONOCLONAL;
ANTIRHEUMATIC AGENTS;
ARTHRITIS, RHEUMATOID;
BIOLOGICAL PRODUCTS;
CLINICAL TRIALS;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
IMMUNOGLOBULIN G;
INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN;
MALE;
PAIN MEASUREMENT;
RANGE OF MOTION, ARTICULAR;
RECEPTORS, TUMOR NECROSIS FACTOR;
SEVERITY OF ILLNESS INDEX;
SIALOGLYCOPROTEINS;
TREATMENT OUTCOME;
|
|
EID: 0036731998
PISSN: 0315162X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (13)
|
|
References (12)
|
